|
12 Jan 2020 |
Announcement of iPSC Derived Gene-modified NK Cell Development Targeting Solid Tumors
|
|
12 Jan 2020 |
Serimmune and Atreca, Inc. Establish Research Collaboration Agreement in Oncology
|
|
12 Jan 2020 |
PACT Pharma Raises $75M in Oversubscribed Series C Financing to Develop Fully Personalized NeoTCR-T Cell Therapies for Patients with Cancer
|
|
12 Jan 2020 |
ViiV Healthcare submits regulatory application to the European Medicines Agency for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available
|
|
12 Jan 2020 |
Terns Pharmaceuticals Presents Results From An Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH
|
|
12 Jan 2020 |
Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study
|
|
12 Jan 2020 |
Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia A and PKU
|
|
12 Jan 2020 |
Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases
|
|
12 Jan 2020 |
Indapta Therapeutics and Lonza Announce Strategic Partnership to Advance a Next-generation, Off-the-shelf, Allogeneic Immuno-oncology Therapy
|
|
12 Jan 2020 |
Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
|
|
12 Jan 2020 |
Amunix Pharmaceuticals Announces Technology Licensing Agreement with Roche to Advance Novel Therapeutics Outside Oncology
|
|
12 Jan 2020 |
Bayer and Azitra partner to harness the human skin microbiome as a source for new natural skin care products for sensitive and eczema-prone skin
|
|
12 Jan 2020 |
Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy
|
|
11 Jan 2020 |
Lilly Announces Agreement to Acquire Dermira
|
|
10 Jan 2020 |
Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery
|
|
10 Jan 2020 |
Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
|
|
09 Jan 2020 |
Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies
|
|
09 Jan 2020 |
Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients
|
|
09 Jan 2020 |
Acepodia Announces FDA Clearance of IND for its NK Cell Therapy Drug Candidate ACE1702 to Treat Patients with HER2-expressing Solid Tumors
|
|
09 Jan 2020 |
Cybrexa Therapeutics Announces CBX-12 as Lead Development Program
|
